Corteva, Inc. against DSM-Firmenich AG — live side-by-side technical comparison.
Prices as of 2026-09-23T20:03:47+00:00 UTC · updates daily
DSFIR.AS leads 4 of the 5 windows we measure — over 1 month CTVA is -2.9% and DSFIR.AS +4.8%; over year to date CTVA is +20.0% and DSFIR.AS +39.3%.
| CTVA | DSFIR.AS | |
|---|---|---|
| Price | $80.42 | $95.76 |
| 1 day | +0.1%lead | -1.4% |
| 5 days | -0.7% | +4.3%lead |
| 1 month | -2.9% | +4.8%lead |
| 6 months | +3.4% | +64.8%lead |
| Year to date | +20.0% | +39.3%lead |
| 52-week position | 65% of range | 96% of range |
| 52-week range | $60.53–$90.97 | $55.22–$97.36 |
| vs 50-day average | below $82.73 | above $90.70 |
| vs 200-day average | above $78.37 | above $73.33 |
| RSI (14) | 18 | 56 |
| Next earnings | 2026-11-03 | 2026-07-30 |
CTVA trades at $80.42, below its 50-day average of $82.73, and above the 200-day at $78.37. It sits at 65% of its 52-week range ($60.53–$90.97); 14-day RSI is 18, in oversold territory; an average session moves it about 3.1%. For levels, the first level overhead is $82.73 (2.9% away) and the first support below is $80.00 (0.5% down). On the checklist the page runs for every asset, 2 of 6 checks read bullish — the lean is bearish.
DSFIR.AS trades at $95.76, above its 50-day average of $90.70, and above the 200-day at $73.33. It sits at 96% of its 52-week range ($55.22–$97.36); 14-day RSI is 56, in neutral territory; an average session moves it about 2.3%. For levels, the first level overhead is $97.12 (1.4% away) and the first support below is $90.70 (5.3% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
CTVA is the more volatile of the two — an average session moves it 3.1% against 2.3% for DSFIR.AS, so an identical position size carries roughly 1.3× the daily risk.
The comparison turns on those levels: CTVA clearing $82.73 or losing $80.00; DSFIR.AS clearing $97.12 or losing $90.70. Until one of them gives way, the relative reading above stands.